Cargando…
The Role of Pharmaceuticals in Reducing Cardiometabolic Risk: Rethinking Pharmacy Benefit Design to Reduce the Burden on the Health Care System
OBJECTIVES: To summarize the challenges facing the U.S. health care systembetween now and 2013. SUMMARY: Between now and 2013, the American health care system will need tomake major changes to successfully address Medicare’s funding challenges. Makingthe patient a partner in care, developing systems...
Autores principales: | Chao, Schumarry H., Davis, Stephen N., Thompson, Tommy G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Academy of Managed Care Pharmacy
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10437347/ http://dx.doi.org/10.18553/jmcp.2006.12.s1-A.1 |
Ejemplares similares
-
From Adherence to Outcomes: Impact of Benefit Design on the HIV Patient
por: Chao, Schumarry H., et al.
Publicado: (2006) -
Blurring Lines of Medical and Pharmacy Management: The New Role of Specialty Pharmaceuticals
por: Sullivan, Sean D., et al.
Publicado: (2008) -
Modernization Versus Limitation: Cross-Firing the Impact of the AHRQ Effective Health Care Program on Access to Biologic Therapies
por: Chao, Schumarry H., et al.
Publicado: (2007) -
Shifting the Focus From Cost to Value: Key Stakeholder Perspectives
por: Chao, Schumarry H., et al.
Publicado: (2006) -
Global Cholera Epidemiology: Opportunities to Reduce the Burden of Cholera by 2030
por: Legros, Dominique
Publicado: (2018)